Evidence map›Paper›PMID 41281291›Full record

ArticleFrontiers in digital health2025

Adopting machine learning to predict breast cancer patients adherence with lifestyle recommendations and quality of life outcomes.

Anna Crispo, Maria Elisabetta Pagnano, Agnese Bonfigli, Leandro Pecchia, Assunta Luongo, Giuseppe Porciello, Sergio Coluccia, Melania Prete, Luca Bacco, Sara Vitale and 13 more

Erratum issuedAbstract read
In one paragraph

Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Anna CrispoEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Maria Elisabetta PagnanoResearch Unit of Intelligent Health-Technologies, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Agnese BonfigliResearch Unit of Intelligent Health-Technologies, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Leandro PecchiaResearch Unit of Intelligent Health-Technologies, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Assunta LuongoEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Giuseppe PorcielloEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Sergio ColucciaBranch of Medical Statistics, Biometry and Epidemiology "G. A. Maccacaro", Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.
Melania PreteEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Luca BaccoResearch Unit of Computer System and Bioinformatics, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Sara VitaleEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Elvira PalumboEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Paolo GiacconeResearch Unit of Intelligent Health-Technologies, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Rosa PicaEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Maria GrimaldiEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Marco CascellaAnesthesia and Pain Medicine, Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy.
Ernesta CavalcantiDivision of Laboratory Medicine, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Anita MinopoliDivision of Laboratory Medicine, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Michelino De LaurentiisDivision of Breast Medical Oncology, Department of Breast and Thoracic Oncology Director, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Massimo LibraDepartment of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.
Jerry PoleselCancer Epidemiology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Samuele MassarutBreast Surgical Oncology Unit, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.
Egidio CelentanoEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.
Livia S A AugustinEpidemiology and Biostatistics Unit, Istituto Nazionale Tumori - IRCCS, "Fondazione G. Pascale", Naples, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Healthy lifestyle behaviors and improved quality of life have been associated with better prognoses in breast cancer survivors. However, sustaining behavioral changes remains challenging; therefore, identifying effective components of lifestyle education programs is essential to enhance adherence, improve quality of life, and facilitate their integration into clinical practice. This study aimed to predict patient adherence to a lifestyle intervention of diet, physical activity, and vitamin D supplementation and to forecast the most frequent Health-Related Quality of Life over the subsequent three measurements. Methods: A total of 316 breast cancer survivors were included in the analysis. Adherence was modeled as a multi-label time series classification task, with compliance recorded on a three-point scale for each treatment component at quarterly intervals over one year. Health-Related Quality of Life was predicted by evaluating first-year adherence data to estimate the mean score over the subsequent three measurements. Results: The dataset was split into 70% for training and 30% for evaluation. Random forest classifiers were employed for adherence prediction, achieving accuracy of up to 81%. An XGBoost regressor was used for Health-Related quality of life prediction, and it was compared to a baseline linear regression model. XGBoost demonstrated superior predictive performance, achieving an R-squared value of 0.62. Discussion: Our findings highlight the promise of machine learning techniques in supporting personalized medicine. Advanced predictive models may aid in identifying patients at risk of non-adherence, enabling early interventions, and improving long-term outcomes through tailored lifestyle strategies for breast cancer survivors.

Indexed as

breast cancerdiethealth-related quality of lifemachine learningmissing data

Identifiers

PMID41281291
PMCPMC12631627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.